• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔崩解片在体外口腔模型中的表现:一项初步研究。

How Do Orodispersible Tablets Behave in an In Vitro Oral Cavity Model: A Pilot Study.

作者信息

Desai Neel, Redfearn Andrew, MacLeod Graeme, Tuleu Catherine, Hanson Ben, Orlu Mine

机构信息

Department of Pharmaceutics, School of Pharmacy, University College London, London WC1N 1AX, UK.

SPI Pharma Inc., 503 Carr Road, Wilmington, DE 19809, USA.

出版信息

Pharmaceutics. 2020 Jul 9;12(7):651. doi: 10.3390/pharmaceutics12070651.

DOI:10.3390/pharmaceutics12070651
PMID:32660030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7408023/
Abstract

Orodispersible tablets (ODTs) offer rapid disintegration of the dosage form when placed on the tongue, which leads to fast release of the active pharmaceutical ingredient. Despite increased use in diverse patient populations, there have been numerous challenges associated with ODTs. One such concern is the lack of standardised assessment of disintegration behaviour. In the European Pharmacopoeia, 'orodispersibles' are defined as such if disintegration time is faster than 3 min. Common in vitro measurement methods only provide single time point data and have limited physiological accuracy. To determine more bio-predictive disintegration kinetics, a bench-top in vitro oral cavity model (OCM) was modified and piloted to assess disintegration of three ODTs of differing hardness. All ODTs disintegrated similarly within the OCM-surface breakdown/swelling, initial 'wash away' and final 'wash away'. The distinct advantage presented within this pilot study using the OCM is the opportunity to ascertain disintegration behaviour profiles of ODTs by evaluating changes in the observable area during simulated oral processing. The model could be implemented as a decision-support tool during the early stages of the drug design process to improve acceptability and further understand ODT disintegration behaviour.

摘要

口腔崩解片(ODTs)置于舌上时剂型能迅速崩解,从而使活性药物成分快速释放。尽管在不同患者群体中的使用日益增加,但口腔崩解片仍存在诸多挑战。其中一个问题是缺乏对崩解行为的标准化评估。在欧洲药典中,如果崩解时间快于3分钟,“口腔崩解片”即如此定义。常见的体外测量方法仅提供单个时间点的数据,且生理准确性有限。为了确定更具生物预测性的崩解动力学,对台式体外口腔模型(OCM)进行了改进和试点,以评估三种硬度不同的口腔崩解片的崩解情况。所有口腔崩解片在口腔模型表面的分解/膨胀、初始“冲蚀”和最终“冲蚀”过程中的崩解情况相似。在这项使用口腔模型的试点研究中呈现的明显优势是,有机会通过评估模拟口腔处理过程中可观察区域的变化来确定口腔崩解片的崩解行为特征。该模型可在药物设计过程的早期阶段作为决策支持工具实施,以提高可接受性并进一步了解口腔崩解片的崩解行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd5/7408023/a817b705a055/pharmaceutics-12-00651-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd5/7408023/bd1506680f78/pharmaceutics-12-00651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd5/7408023/17d7e9f6ccb5/pharmaceutics-12-00651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd5/7408023/4d48f213d1ea/pharmaceutics-12-00651-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd5/7408023/a817b705a055/pharmaceutics-12-00651-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd5/7408023/bd1506680f78/pharmaceutics-12-00651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd5/7408023/17d7e9f6ccb5/pharmaceutics-12-00651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd5/7408023/4d48f213d1ea/pharmaceutics-12-00651-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd5/7408023/a817b705a055/pharmaceutics-12-00651-g004.jpg

相似文献

1
How Do Orodispersible Tablets Behave in an In Vitro Oral Cavity Model: A Pilot Study.口腔崩解片在体外口腔模型中的表现:一项初步研究。
Pharmaceutics. 2020 Jul 9;12(7):651. doi: 10.3390/pharmaceutics12070651.
2
An in vitro analysis of disintegration times of different formulations of olanzapine orodispersible tablet: a preliminary report.不同奥氮平口腔崩解片配方崩解时间的体外分析:初步报告。
Drugs R D. 2013 Dec;13(4):281-8. doi: 10.1007/s40268-013-0030-8.
3
Testing the disintegration and texture-related palatability predictions for orodispersible tablets using an instrumental tool coupled with multivariate analysis: Focus on process variables and analysis settings.使用结合多变量分析的仪器工具测试口腔崩解片的崩解和质地相关适口性预测:关注工艺变量和分析设置。
Eur J Pharm Sci. 2024 Jul 1;198:106801. doi: 10.1016/j.ejps.2024.106801. Epub 2024 May 15.
4
Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.Prosolv和Prosolv:甘露醇200直接压片填充剂对阿托伐他汀口腔崩解片物理机械性能的影响。
Pharm Dev Technol. 2015 Jun;20(4):394-400. doi: 10.3109/10837450.2013.871031. Epub 2014 Jan 8.
5
Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.双氯芬酸掩味口腔崩解片制剂的设计、开发及体外评价
Drug Dev Ind Pharm. 2015 Apr;41(4):540-51. doi: 10.3109/03639045.2014.884122. Epub 2014 Feb 5.
6
Assessment of oral formulation-dependent characteristics of orodispersible tablets using texture profiles and multivariate data analysis.采用质构分析和多元数据分析评估口腔速溶片的制剂依赖特性。
J Pharm Biomed Anal. 2018 Apr 15;152:47-56. doi: 10.1016/j.jpba.2018.01.040. Epub 2018 Feb 3.
7
Puzzle out Machine Learning Model-Explaining Disintegration Process in ODTs.破解机器学习模型——解释口腔崩解片的崩解过程
Pharmaceutics. 2022 Apr 13;14(4):859. doi: 10.3390/pharmaceutics14040859.
8
A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.一种用于口腔崩解片的新型改良湿润试验和替代崩解试验。
J Pharm Biomed Anal. 2016 Feb 20;120:391-6. doi: 10.1016/j.jpba.2015.12.046. Epub 2015 Dec 29.
9
Clinical disintegration time of orally disintegrating tablets clinically available in Japan in healthy volunteers.日本市售口崩片在健康志愿者中的临床崩解时间。
Biol Pharm Bull. 2013;36(9):1488-93. doi: 10.1248/bpb.b13-00353.
10
A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation.氯唑沙宗口腔崩解片的药学研究:处方、体外及体内评价
Drug Deliv. 2016 Oct;23(8):2998-3007. doi: 10.3109/10717544.2016.1138340. Epub 2016 Feb 1.

引用本文的文献

1
Assessing disintegration effectiveness: A thorough evaluation using the SeDeM-ODT expert system for doxylamine succinate orodispersible formulation.评估崩解效果:使用 SeDeM-ODT 专家系统对琥珀酸多西拉敏速溶片进行全面评估。
PLoS One. 2024 Sep 17;19(9):e0310334. doi: 10.1371/journal.pone.0310334. eCollection 2024.
2
Orally Dispersible Dosage Forms for Paediatric Use: Current Knowledge and Development of Nanostructure-Based Formulations.儿科用口腔崩解剂型:当前认知及基于纳米结构制剂的开发
Pharmaceutics. 2022 Aug 3;14(8):1621. doi: 10.3390/pharmaceutics14081621.
3
Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 2-Factorial Design.

本文引用的文献

1
In Vitro Oral Cavity Model for Screening the Disintegration Behavior of Orodispersible Films: A Bespoke Design.用于筛选口溶膜崩解行为的体外口腔模型:定制设计。
J Pharm Sci. 2019 May;108(5):1831-1836. doi: 10.1016/j.xphs.2018.12.025. Epub 2019 Jan 11.
2
Co-Processed Excipients for Dispersible Tablets-Part 1: Manufacturability.共处理辅料用于分散片-第 1 部分:可制造性。
AAPS PharmSciTech. 2018 Aug;19(6):2598-2609. doi: 10.1208/s12249-018-1090-4. Epub 2018 Jun 18.
3
In vitro characterization and mouthfeel study of functionalized calcium carbonate in orally disintegrating tablets.
采用二因素设计开发和评价大麻二酚口腔崩解片
Pharmaceutics. 2022 Jul 14;14(7):1467. doi: 10.3390/pharmaceutics14071467.
4
Modernising Orodispersible Film Characterisation to Improve Palatability and Acceptability Using a Toolbox of Techniques.利用技术工具箱使口腔崩解膜表征现代化以提高适口性和可接受性
Pharmaceutics. 2022 Mar 29;14(4):732. doi: 10.3390/pharmaceutics14040732.
5
Machine Learning and Machine Vision Accelerate 3D Printed Orodispersible Film Development.机器学习与机器视觉加速3D打印口腔崩解膜的研发。
Pharmaceutics. 2021 Dec 17;13(12):2187. doi: 10.3390/pharmaceutics13122187.
6
Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets.大麻二酚口腔崩解片的药剂学和分析前制剂研究
Saudi Pharm J. 2021 Sep;29(9):1029-1042. doi: 10.1016/j.jsps.2021.07.012. Epub 2021 Jul 17.
在口腔崩解片中功能化碳酸钙的体外特性和口感研究。
Int J Pharm. 2017 Dec 20;534(1-2):50-59. doi: 10.1016/j.ijpharm.2017.10.009. Epub 2017 Oct 4.
4
Medicines for children: flexible solid oral formulations.儿童用药:灵活的固体口服制剂
Bull World Health Organ. 2017 Mar 1;95(3):238-240. doi: 10.2471/BLT.16.171967.
5
Tongue thickness evaluation using ultrasonography can predict swallowing function in amyotrophic lateral sclerosis patients.使用超声检查评估舌厚度可预测肌萎缩侧索硬化症患者的吞咽功能。
Clin Neurophysiol. 2016 Feb;127(2):1669-1674. doi: 10.1016/j.clinph.2015.07.032. Epub 2015 Aug 21.
6
Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.儿科口服给药的制剂方法:当前平台的优势与局限
Expert Opin Drug Deliv. 2015;12(11):1727-40. doi: 10.1517/17425247.2015.1060218. Epub 2015 Jul 13.
7
Effect of granule properties on rough mouth feel and palatability of orally disintegrating tablets.颗粒性质对口腔崩解片粗糙口感和可接受性的影响。
Int J Pharm. 2015 Apr 30;484(1-2):156-62. doi: 10.1016/j.ijpharm.2015.02.023. Epub 2015 Feb 11.
8
Characterisation of human saliva as a platform for oral dissolution medium development.将人类唾液表征为用于口腔溶出介质开发的平台。
Eur J Pharm Biopharm. 2015 Apr;91:16-24. doi: 10.1016/j.ejpb.2015.01.007. Epub 2015 Jan 17.
9
Dissolution methodology for taste masked oral dosage forms.掩味口服剂型的溶出度方法。
J Control Release. 2014 Jan 10;173:32-42. doi: 10.1016/j.jconrel.2013.10.030. Epub 2013 Oct 31.
10
Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.评价新型崩解仪用于口崩片(ODT)直接压片的共处理辅料。
Pharm Dev Technol. 2013 Mar-Apr;18(2):464-74. doi: 10.3109/10837450.2012.710238. Epub 2012 Aug 13.